NO983512L - Midler for behandling og forhindring av AIDS - Google Patents

Midler for behandling og forhindring av AIDS

Info

Publication number
NO983512L
NO983512L NO983512A NO983512A NO983512L NO 983512 L NO983512 L NO 983512L NO 983512 A NO983512 A NO 983512A NO 983512 A NO983512 A NO 983512A NO 983512 L NO983512 L NO 983512L
Authority
NO
Norway
Prior art keywords
aids
drugs selected
prevention
treatment
hiv
Prior art date
Application number
NO983512A
Other languages
English (en)
Norwegian (no)
Other versions
NO983512D0 (no
Inventor
Tomoaki Komai
Toshinori Ohmine
Takashi Nishigaki
Tomio Kimura
Tetsushi Katsube
Original Assignee
Sankyo Co
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co, Ube Industries filed Critical Sankyo Co
Publication of NO983512D0 publication Critical patent/NO983512D0/no
Publication of NO983512L publication Critical patent/NO983512L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO983512A 1996-01-31 1998-07-30 Midler for behandling og forhindring av AIDS NO983512L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1482596 1996-01-31
PCT/JP1997/000218 WO1997027856A1 (en) 1996-01-31 1997-01-30 Remedies or preventives for aids

Publications (2)

Publication Number Publication Date
NO983512D0 NO983512D0 (no) 1998-07-30
NO983512L true NO983512L (no) 1998-09-30

Family

ID=11871826

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983512A NO983512L (no) 1996-01-31 1998-07-30 Midler for behandling og forhindring av AIDS

Country Status (9)

Country Link
EP (1) EP0878194A1 (cs)
KR (1) KR19990082201A (cs)
CN (1) CN1214632A (cs)
AU (1) AU713704B2 (cs)
CA (1) CA2245179A1 (cs)
CZ (1) CZ238698A3 (cs)
HU (1) HUP9901642A3 (cs)
NO (1) NO983512L (cs)
WO (1) WO1997027856A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020068749A1 (en) * 1996-11-08 2002-06-06 Hideharu Sato Aids remedy
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
BR0111678A (pt) * 2000-06-13 2003-06-03 Shionogi & Co Composições medicinais contendo derivados de propenona
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
WO2006089054A1 (en) 2005-02-16 2006-08-24 Achillion Pharmaceuticals, Inc. New isothiazoloquinolones and related compounds as anti-infective agents
ATE482208T1 (de) * 2004-03-10 2010-10-15 Us Of America Represented By T Chinolin-4-one als inhibitoren der retroviralen integrase zur behandlung von hiv, aids und aids- related complex (arc)
US7659399B2 (en) 2005-01-05 2010-02-09 Achillion Pharmaceuticals, Inc. 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents
US7199128B2 (en) 2005-02-02 2007-04-03 Achillion Pharmaceuticals, Inc. 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
CA2616768C (en) 2005-07-27 2014-05-06 Achillion Pharmaceuticals, Inc. 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
AU2009322170A1 (en) * 2008-12-05 2011-07-14 Medicines For Malaria Venture Compounds having antiparasitic or anti-infectious activity
US8598354B2 (en) 2008-12-05 2013-12-03 University Of South Florida Compounds having antiparasitic or anti-infectious activity
EP2414368B1 (en) 2009-04-03 2013-11-27 Achillion Pharmaceuticals, Inc. Hydroxythienoquinolones and related compounds as anti-infective agents
ES2714705T3 (es) * 2013-07-10 2019-05-29 Meiji Seika Pharma Co Ltd Inhibidor de PDE4 novedoso
WO2015078799A1 (en) * 2013-11-27 2015-06-04 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
CN103961684B (zh) * 2014-05-23 2016-05-18 滨州医学院 沙奎拉韦在制备预防或治疗肺纤维化的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2993316B2 (ja) * 1992-05-27 1999-12-20 宇部興産株式会社 アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
JPH08311024A (ja) * 1995-03-15 1996-11-26 Sankyo Co Ltd Ahpba構造含有ジペプチド化合物

Also Published As

Publication number Publication date
CA2245179A1 (en) 1997-08-07
EP0878194A1 (en) 1998-11-18
NO983512D0 (no) 1998-07-30
CZ238698A3 (cs) 1998-12-16
AU1556497A (en) 1997-08-22
AU713704B2 (en) 1999-12-09
HUP9901642A3 (en) 2000-07-28
KR19990082201A (ko) 1999-11-25
CN1214632A (zh) 1999-04-21
WO1997027856A1 (en) 1997-08-07
HUP9901642A2 (hu) 1999-09-28

Similar Documents

Publication Publication Date Title
NO983512L (no) Midler for behandling og forhindring av AIDS
TR200401663T1 (tr) 4-oksokuinolin bileşiği ve bunun HIV integraz inhibitörü olarak kullanımı.
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
NO962162D0 (no) Dipeptider som bevirker frigjöring av veksthormon
SE9604793L (sv) Nya Kristallmodifikationer
NO954427D0 (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
LV12719A (lv) Benzoxazinones as inhibitors of hiv reverse transcriptase
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
BR9912066A (pt) Uso de um ingrediente ativo; método de tratamento de restenose; e; composição farmacêutica
EE04376B1 (et) Bis-aminohappe hüdroksüetüülamino-sulfoonamiidsedretroviirusliku proteaasi inhibiitorid
ME00578A (en) Use of gastrointestinal lipase inhibitors
UA27870C2 (uk) Фармацевтичний препарат
MX9706947A (es) Inhibidores de proteasa retroviral de sulfonilalcanoilamino-hidroxietilamino-sulfonamida y uso de los mismos.
DE69928779D1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
NO993670L (no) Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS
NO934721D0 (no) Hemmere av HIV-protease som er nyttige for behandling av AIDS
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
WO2004101512A3 (en) Naphthyridine integrase inhibitors
MY121604A (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt
MX9704024A (es) Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1.
MXPA04004061A (es) Derivados de quinolina y piridina antiretrovirales.
FR2787028B1 (fr) Utilisation du riluzole dans le traitement des traumatismes acoustiques
ZA200207586B (en) Diphenyl ketoaldehyde derivatives with anti-HIV activity.
ES2195905T3 (es) Compuestos de tiofen-etil-tiourea y su uso en el tratamiento de sida.
ES2190456T3 (es) Combinacion de inhibidores de la proteasa del vih.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application